Danaher Co. (NYSE:DHR) CEO Rainer Blair Sells 19,085 Shares

Danaher Co. (NYSE:DHR) CEO Rainer Blair sold 19,085 shares of the company’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $255.00, for a total transaction of $4,866,675.00. Following the transaction, the chief executive officer now directly owns 115,995 shares of the company’s stock, valued at $29,578,725. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Rainer Blair also recently made the following trade(s):

• On Wednesday, April 24th, Rainer Blair sold 47,175 shares of Danaher stock. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50.

Danaher Stock Performance

Shares of NYSE:DHR traded up $0.24 during trading on Thursday, hitting $263.70. The company’s stock had a trading volume of 1,220,188 shares, compared to its average volume of 2,680,702. The company has a 50-day moving average of $248.28 and a 200-day moving average of $235.43. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The firm has a market cap of $195.32 billion, a price-to-earnings ratio of 44.62, a P/E/G ratio of 3.87 and a beta of 0.83. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $264.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The company’s quarterly revenue was down 2.6% on a year-over-year basis. During the same period last year, the firm earned $2.36 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.41%. The ex-dividend date of this dividend is Friday, June 28th. Danaher’s payout ratio is 18.31%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Citigroup increased their price target on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. KeyCorp increased their price target on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. Royal Bank of Canada upped their price objective on Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Raymond James lifted their target price on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Finally, Bank of America upped their price target on Danaher from $258.00 to $270.00 and gave the company a “neutral” rating in a report on Wednesday, April 24th. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $267.31.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in Danaher by 7.4% during the first quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate’s stock valued at $15,009,928,000 after purchasing an additional 4,163,657 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Danaher by 12.0% during the 4th quarter. Wellington Management Group LLP now owns 27,928,442 shares of the conglomerate’s stock valued at $6,460,966,000 after purchasing an additional 2,998,161 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Danaher by 10.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,757,558 shares of the conglomerate’s stock valued at $3,876,694,000 after buying an additional 1,619,586 shares in the last quarter. Capital International Investors boosted its holdings in Danaher by 9.1% in the 4th quarter. Capital International Investors now owns 15,956,519 shares of the conglomerate’s stock worth $3,691,735,000 after buying an additional 1,334,781 shares during the period. Finally, Northern Trust Corp increased its stake in Danaher by 1.7% in the 3rd quarter. Northern Trust Corp now owns 8,100,722 shares of the conglomerate’s stock worth $2,009,789,000 after buying an additional 134,905 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.